Difficulty: Medium
Average Score: 94%
Practice
Animal testing of potential new therapeutic agents
Correct answer
C
Rationale
The correct answer is that animal testing requires the submission of histopathologic slides and specimens to the FDA (C), part of preclinical data in the Investigational New Drug (IND) application, ensuring safety evaluation. Option A is false; testing duration varies (months to years), not fixed at 3 years. Option B is incorrect; two species (e.g., rodent and non-rodent like dog) are typical, not necessarily primates. Option D is wrong; allergy prediction is poor in animals due to immune differences. Option E (original) about abbreviation for toxic agents is true but less defining. This regulatory step validates toxicity and pharmacology data, bridging preclinical and human trials.